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Following the adaptation of the MEF1 strain of poliomyelitis virus to infant 
mice, Casals,  Olitsky, and Anslow  (1)  were able to prepare from the central 
nervous system  of  these mice an  antigen  for the  detection of complement- 
fixing (c-f) antibodies to Type 2 poliomyelitis virus (2). Thus, another param- 
eter different from the neutralizing antibody test, has been added for measur- 
ing poliomyelitis infection in man. It was felt that in addition to being another 
measure  of  "immunity,"  c-f antibodies  might  perhaps  prove  to  differ from 
neutralizing antibodies  in  their  persistence  in  man.  And,  if  this  were  true, 
determinations  of  both  antibodies  might  indicate  more  precisely  the  time 
of exposure to poliomyelitis virus. 
This paper deals with: (a) The age distribution of c-f antibodies to Type 2 
poliomyelitis virus in a  normal population of a  subtropical area.  (b) The cor- 
relation, if any, between c-f and neutralizing antibodies to the same immuno- 
logical type of virus.  (c) The fate of c-f antibodies in the same individuals in 
the course of an 18 month period. 
In order to investigate these problems, sera previously collected in 1950 in 
the  vicinity  of  Cairo,  Egypt,  have  been  studied?  Although  poliomyelitis 
epedemics  have not been reported  in  the  native  population  in  Cairo,  the 
disease is endemic and Paul et al.  (3, 4) have commented in two previous re- 
ports on the large number of infantile cases seen at one local children's hos- 
pital.  In the population of this area,  neutralizing antibodies to all three im- 
munological types of poliomyelitis virus were acquired early in life indicating 
that virtually all children above the age of 3 had been exposed (4). The almost 
universal presence of antibodies in those older than 3 years partially explains 
the infantile nature of the disease in Cairo. Because virtually all the population 
* Aided by a grant from The National Foundation for Infantile Paralysis, Inc. 
$ Fellow of the Israeli Government. 
i We are indebted to Dr. John R. Paul for making these valuable sera available to us. 
The circumstances under which they were collected have been reported previously (4), to- 
gether with acknowledgments  to the various people and organizations  who assisted in making 
possible their collection. 
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was exposed here early in life, it was felt that a  study of c-f antibodies in Cairo 
could  be  interpreted  more  easily  than  in  an  area  in  this  country  where  the 
acquisition of antibodies is delayed over a  longer period in life (5, 6). 
In addition to the sera collected by Dr. Paul, a  second bleeding was obtained 
from 16 children,  18 months after they were first bled in 1950.  The latter sera 
were kindly furnished us by Dr. Richard M. Taylor of The Rockefeller Founda- 
tion.~ 
Materials and Methods 
The MEF1 "infant mouse-adapted" strain of poliomyelitis virus was used as a  source of 
antigen. This strain was kinaly supplied by Dr, Casals and Dr. Olitsky in the 48th and 79th 
mouse  passage.  Brains  of infected mice in the 80  to 85th  passages  were mainly  used  as 
these materials gave higher infectivity titers and yielded more potent antigens than the earlier 
ones. Such brains yielded m60 titers in infant mice, following intracerebral inoculation, between 
10-8.6 and 10 -4.7, and 10-  6 in adult mice. Antigens were prepared by intracerebral inoculation 
of mice less than 2 days old. When inoculated with a 20 per cent suspension of infected infant 
mouse brains, the mice came down with limb paralysis, on the average as follows: 23 per cent 
on the 2nd day after inooalation, 57 per cent on the 3rd day, and the remaining 20 per cent on 
the 4th day. After testing antigens prepared from infant mouse brains harvested on the 2nd 
and 3rd day respectively, we found no significant difference in the titers of the antigens whether 
paralyzed or non-paralyzed mice were used for harvest. Consequently we made it a practice 
to harvest all mice approximately 60 hours after inoculation. For the preparation of antigens 
we used brains exclusively. Casals, Olitsky, and Anslow (2) found that spinal cords of infected 
mice yielded slightly more potent antigens than brains but the difference was not great. As 
it is so much easier and more convenient to use only brains, we adopted it as a  method of 
choice. Specific  reactions were obtained using acetone-ether extraction of the brains as de- 
scribed by Casals (7). As about 1 to 2 per cent of human sera reacted with the antigen from 
normal infant mouse brains prepared by the latter method, normal infant mouse brain anti- 
gens had to be included in each test, or, sera which gave fixation of complement in the presence 
of the MEF1 antigen had  to be retested with the normal antigen.  Sera were stored frozen 
from the time of collection; they were thawed  occasionally for  antibody  tests.  Before use, 
all sera were inactivated at 60 ° C. for 20 minutes. 
Every batch of antigen was tested for antigenic potency as well as for anticomplementary 
activity. Usually the latter activity was low, while the antigenic potency was high; when a 
"box titration" against homologous monkey antiserum was carried out, the antigen diluted 
to 1:8 still reacted with the antiserum at a dilution of 1:256. 4 antigenic units were used for 
screening human sera, 1 antigenic unit being defined as the highest dilution of antigen (con- 
tained in 0.1 ml.) that reacted to a high titer (at least 1:32) with homologous monkey anti- 
serum. 
The type of complement fixation used was a modified Kolmer test based on 100 per cent 
hemolysis. Serum, antigen, and complement (2 units) were added in 0.1 ml. increments each 
and after overnight incubation at 4 ° C., 0.2 ml. of a sensitized suspension  of sheep red blood 
cells was added, the mixture kept for 30 minutes at 37 ° C. and read. 
In the neutralization tests, the Lansing~strain of poliomyelitis virus was used; the details 
of the qualitative tests have been descril3"ed in a  previous paper from this laboratory  (4). 
i We are also indebted to Capt. James J. Sapero (MC), U.S.N., Commanding Officer of 
Naval Medical Research Unit (NAMRU) No. 3, for providing certain laboratory facilities and 
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For the quantitative  tests carried out on a selected number of sera, a fixed dose of 100 IDso 
(final dilution) of virus was used against fivefold serial dilutions of serum, ranging from 1:2 
to 1:250. The titer of neutralizing antibody was determined using the 50 per cent end-point 
calculated by the Reed-Muench method. 
RESULTS 
In order to find the range of reactivity of human sera with the  MEF1 anti- 
gen, preliminary titrations  were run,  and soon it became clear that  the reac- 
tivity ranged from 1:4 to 1:16 serum dilutions; sera positive at 1:2 and nega- 
tive  at  1:4 were  an unusual  finding and so were sera  with titers  of  1:32  or 
higher.  We  tested,  therefore,  human  sera  by screening  at  1:4 and  titrating 
TABLE I 
Neutralization  and  Complement  Fixation  Tests in Sera Collected in Cairo,  1950 
Age 
~?105. 
0-3 
4-6 
7-12 
:YRS. 
1 
2 
3.-4 
5.-9 
10-14 
15-29 
30+ 
rotal... 
Lansing neutralization 
No. tested  Positive 
per cenl 
10  8O 
11  55 
15  7 
30  57 
34  79 
35  88 
37  89 
27  93 
22  95 
27  96 
248 
MEF1 complement fixation 
No. tested 
22 
27 
31 
21 
21 
19 
10 
171 
Positive at 1:4 
percent 
0 
0 
0 
45 
41 
51 
43 
10 
15 
0 
Positive at 1:16 
per cent 
0 
0 
0 
27 
30 
26 
5 
5 
5 
0 
all  the positive  reacting  sera  at  1:16  (as well  as  testing  them  with  normal 
infant mouse brain antigen). 
The number of sera tested in each age group is shown in Table I. A  total of 
171  Cairo sera were included in the complement fixation tests and the  results 
obtained are represented  in Fig.  1  (together with the neutralization  tests re- 
sults  obtained  in an earlier study from this  laboratory (4)).  It will be noted 
that c-f antibodies are completely absent in children below the age of 1 year. 
The absence of c-f antibodies  in this age group parallels  their scarcity in the 
higher  ages,  from  10 years  on,  and  may be  explained  by  the  fact  that  the 
mothers are devoid of these antibodies and therefore cannot transfer them to 
their  offspring. The rise  of c-f antibodies  starts  steeply at the age of 1 year, 
after which a  sort of plateau,  at the level of 50 per cent, is formed until  the 178  ANTIBODIES  TO  TYPE  2  POLIOMYELITIS  VIRUS 
,oo  t 
70  ._~  eo 
50 
40 
30 
20 
10 
0  to)  ¢@  ¢~ 
Age  "°s'6  ';"  T 
Yrs.  i,. 
• Neutralizing  antibodies-  Lansing  strain 
°  Complement  antibodies  ~./  "~.  -fixing  -  MEFI  strain 
~.~  Serum  1:4 
--se  ~'~  ........  N~. .rum  ,:,sNNX. 
I  2  3-4  5-9  10-14  15"29  30+ 
Fzo. i. Neutralizing and complement-fixing  antibodies to Type 2 poliomyelitis  virus in 
the native population of Cairo. 
1950  I 
32 
16 
Age  in  1950 
FIO. 2. MEF1  complement fixation titers of sera from 16 Cairo children bled in 1950 and 
again in 1952. 
age of 5 to 9 years. After that age there is a steep fall in the antibody level, 
nearly to 0,  the older age groups being practically devoid of c-f antibodies. 
The curve at serum dilution of 1:16 gives additional information by showing NATAN  GOLDBLUM  AND  JOSEPH  L.  MELNICK  179 
that the percentages of positives  are lower than that obtained with a serum dilu- 
tion of 1: 4 and that at the age of 5 to 9 years the percentage of reactors dropped 
very significantly, almost to O. 
TABLE II 
MEF1 Complement Fixallon Results ugth Sera from 16 Children Bledin 1950 and A gain in 1952 
No. of children .............................. 
No. of children .............................. 
1950  1952 
-F  --  --  +  --  -- 
1 
TABLE III 
NentraUza~ion and Complement Fixation Tests u~h Sera flora 16 Cairo Children Bled in 1950 
and Again in 1952 
No. of serum 
288 
291 
270 
285 
286 
253 
219 
268 
277 
234 
272 
218 
228 
238 
201 
222 
Age in 1950 
fno$. 
7 
7 
7 
8 
11 
13 
18 
25 
33 
36 
36 
36 
36 
36 
48 
48 
MEF1 complement fixation 
serum titer 
1950  1952 
0  0 
0  0 
0  8 
0  4 
0  0 
4  0 
0  8 
8  16 
4  16 
0  0 
0  0 
4  4 
32  16 
0  8 
4  8 
>32  >32 
Lansing neutralization 
serum titer* 
1950  1952 
0  25 
0  50 
0  >250 
0  >250 
0  150 
0  5 
0  > 250 
150  >250 
>250  100 
30  10 
0  150 
250  150 
250  > 250 
30  >250 
<5  100 
> 250  > 250 
* i00 IDa0 of virus used in each test.  Sera were used at final dilutions of 1:2, I:10, 1:50, 
1:250. 
0 indicates no neutralization at 1:2. The other titers are given as 50 per cent protection 
end-point. 
Previous results show that Type 2 neutralizing antibodies, also represented 
in Fig. 1 and Table I, follow quite a  different course (4). Following the loss of 
the parental antibody, there was a  very sharp rise, paralleling at  this stage 
the c-f antibodies, and reaching an 80 per cent level at the age  of  2  years, 
and this high level was retained at 88 to 96 per cent throughout life. 180  ANTIBODIES  TO  TYPE  2  POLIOMYELITIS  VIRUS 
Repeat Studies on Certain Children First Bled in 1950.--In order to follow 
the fate of c-f antibodies in the very same individuals, 16 of the children, from 
7 months to 4 years old in July, 1950, were bled again by Dr. R. M. Taylor 
in 1952,  18 months later. Sere of the  1950 and  1952 bleedings were  titrated 
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FIo. 3. Combined neutralization and complement fixation results using in the c-f tests 
serum diluted 1:4. 
simultaneously in twofold dilutions, from 1:2 to 1:32. The findings are shown 
in Fig.  2; each pair of columns represents  the titer of both sera of 1 child in 
1950 and 1952, respectively.  Though the number of sera is small,  the results 
show that c-f antibodies are not at all in a static state. Some children who had 
no c-f antibodies in 1950 developed them by 1952; in others rises and falls in 
titer occurred. The over-all changes have been summarized in Table II: of 7 
children who were positive in 1950, 6 remained positive in 1952 and 1 became NATAN  GOLDBLUM AND  JOSEPH  L.  MELNICK  181 
negative; of 9 negative in 1950, 5 remained negative and 4 developed c-f anti- 
bodies. 
Titrations of neutralizing antibodies using a fixed amount of Lansing virus 
were also carried out on the same pairs of sera, and the results are presented 
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in Table III, together with the results of the c-f tests. In general there is a 
correlation between the two antibodies if one considers only those sera with a 
high titer of neutralizing antibodies. All children who were negative in 1950 
and who developed c-f antibodies by 1952, also developed neutralizing anti- 
bodies to a titer  of more  than  1:250  during the  same period  (sera 219, 238, 
270, 285). 
It may also be seen that some children (sera  288, 291, 286, 272) who failed 182  ANTIBODIES  TO  TYPE  2  POLIOMYELITIS  VIRUS 
to develop c-f antibodies, did develop neutralizing antibodies although of lower 
titer  than found in  children in whom c-f antibodies made their  appearance. 
There seem to be two possible explanations for the latter finding: (a) c-f anti- 
bodies may have formed during the 18 month period and then disappeared by 
the time of the second bleeding,  or  (b)  the infection with poliomyelitis virus 
had been so minimal that c-f antibodies had not yet reached a detectable level 
at the time of the second bleeding. 
TABLE IV 
Calculation of Age-Specific Rates  for Each A ntibody Pattern 
Antibody 
pattern 
:-f neg., 
neut. 
pos. 
,7.-f pos., 
neut. 
pos. 
C-f neg., 
neut. 
neg. 
:-f pos. 
neut. 
neg. 
rotal.. 
Serum dilution 1 to 4 in C-f tests 
Observed Nos. in each 
antibody pattern 
Age in years 
Tots] 
15  <11..45-9  1104" + 
6  31  12  1926 94 
035  ~  2349 
14  13  0  0  0  27 
0  1  0  0  0  1 
20  8C  21  2129171 
Age-specific rate 
Age in years 
<1  1-4  5-9  10-  4  Ixs+ 
3C  39  57  90  9C 
C 44  43  I0  IC 
7C  16  0  0  C 
0  1  0  (~  C 
I100 100 100 10~ 100 
Serum dilution 1 to 16 in C-f test 
Observed Nos. in each 
antibody pattern 
Age in years 
Total 
<1  11.-4 5-9  10-~  15 
14  + 
6  45  20  2C28119 
021  1  1  I  24 
14  14  0  C  £  28 
0  0  0  C 0  0 
20  80  21  21 29 171 
Age-specific  rate 
Age in years 
IN_ 
<1  1--4 5-9  ~  15+ 
30  56  95  95  97 
0  26  5  5  3 
70  18  0  0  0 
0  C  0  0  0 
10~ 100 100 100 IOC 
"Old" and "Recent" Infections.--An  attempt has been made to classify the 
population  sampled  into  three  groups :--those  who  had  "old"  or  "recent" 
infections,  and  those  who had  not  been  infected  with  the  virus.  This  was 
based on the assumption that both complement-fixing and neutralizing anti- 
bodies  are  formed as  a  result  of infection with  Type 2  poliomyelitis virus, 
but  that  they run  a  different  course with  time,  the  neutralizing  antibodies 
being maintained while the c-f antibodies gradually disappear. Thus, a person 
with both antibodies is regarded as having had a relatively recent infection, a 
person with only neutralizing antibodies as having had an old infection, and 
one with no antibodies of either kind, as not having been infected at all.  Figs. 
3  and  4  are  graphic  representations  of  the  findings.  The  numbers  plotted 
were obtained by calculating the age-specific rates in each antibody pattern, NATAN  GOLDBLUM AND  JOSEPH  L.  MELNICK  183 
as shown in Table IV. It will be noticed that:  (a)  the percentage of old infec- 
tions tends to become greater with  advancing  age;  (b)  recent infections  are 
predominantly contracted at the ages of 1 to 9;  and "very  recent" ones (se- 
rum dilution  1:16)  at  1  to 4  years  of age;  (c)  lack  of  infection is confined 
mainly  to  infants  under  1 year;  (at) persons  with  complement-fixing  anti- 
bodies  and  no  neutralizing  antibodies  are  extremely  rare  (only one  being 
found in this series). 
DISCUSSION 
It is too early to draw  far reaching conclusions of epidemiological nature 
from the data reported above. But it is our belief that these findings throw 
some light on problems of infection and immunity in poliomyelitis. Whatever 
bearing c-f antibodies may have on immunity to poliomyelitis, there seems 
little doubt that they represent a  reaction to an infection with poliomyelitis 
virus. Recent observations of Casals  (8) and Svedmyr, Enders, and HoUoway 
(9,  10)  indicate that following infection with one type of poliomyelitis virus, 
transient c-f antibodies  to at least two types may appear,  while the longer 
lasting neutralizing response appears to be restricted to the virus type causing 
the infection. On the other hand, immune animal sera exhibit type-specificity 
in  both  neutralization  and  complement fixation reactions.  3 Similar findings 
have  recently been  made  in  human  infections with  the  Coxsackie  viruses 
(12). Whether or not the c-f response in the Cairo population is type-specific 
seems to be of little importance as far as the temporal pattern of Type 2 c-f 
antibodies is concerned. The reason for this is that  infection with all  three 
known types of poliomyelitis virus occurs early in life (4). In any case the col 
reaction is  certainly different from the  one measured by the  neutralization 
test; for the c-f antibodies are confined to the years of 1 to 9 if a serum dilu- 
tion of 1:4 is used, or to the years 1 to 4 if a serum dilution of 1 : 16 is used. 
We know from morbidity and immunity data (4)  that  in  Cairo the  expo- 
sure to all three immunological types of poliomyelitis virus is confined to very 
early childhood, virtually all  children having been exposed by the age of 3 
years. This brings us close to the problem of whether single or multiple expo- 
sures are necessary for the maintenance of immunity to poliomyelitis, as ex- 
Lahelle (11), using an antigen prepared from brains of infant cotton rats infected with 
the Lansing strain, compared the titers of neutralizing and c-f antibodies in the sera of monkeys 
which received a course of intramuscular vaccinations with active Lansing virus. He found a 
close correlation in the rise of the two antibodies, but the c-f antibodies decreased earlier than 
the neutralizing ones. The c-f titers after increasing to a high level shortly after vaccination 
(1 to 4 weeks)  decreased almost to 0 in a period of 3 months, the neutralizing antibodies re- 
mained at a  relatively high level during this time. Lahelle also observed a  correlation be- 
tween the two kinds of antibodies in the few adult human sera that he tested; on the other 
hand, five sera from children at the age of 1 had no detectable c-f antibodies though all ex- 
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pressed by the presence  of neutralizing antibodies.  If we assume that rein- 
fection after some years would be evidenced by a reappearance (or maintenance 
at detectable levels) of c-f antibodies,  then the data presented are in favor 
of single rather than multiple stimuli. The "single" stimulus may not be con- 
fined to one contact with virus,  but may represent  several  contacts over a 
relatively short period of time. 
In this regard the children who were bled in 1950 and again in 1952 are of 
interest.  Children who developed high titers of neutralizing antibodies in this 
period,  also  developed c-f antibodies,  and  may represent  those  individuals 
exposed  to  repeated and perhaps  large doses  of virus.  On  the  other hand, 
children who developed low titers of neutralizing antibodies and no detectable 
c-f antibodies may represent those exposed to a single stimulus. Possibly such 
children on repeated exposure may show a rise in neutralizing antibody titer~ 
together with the appearance of c-f antibodies. 
The results of the present study are in accord with the observations of Paul 
and Riordan (13)  that a  single stimulus (or multiple stimuli during a  short 
period of time) is sufficient for the production of neutralizing antibodies and 
their maintenance over long periods of time. Experimental data on the oral 
infection of chimpanzees with poliomyelitis virus also show that neutralizing 
antibodies are maintained for long periods--at least 6 years (14). 
However, it is clear that one cannot generalize from the Cairo results, for 
in a  survey of c-f antibodies to Type 2 poliomyelitis virus in this country 
(Charleston, West Virginia,  1951) it was found (15)  that the c-f curve dis- 
plays a  different course---pointing to different mechanisms of exposure from 
those in Cairo. The c-f antibody curve of Charleston rises at the age of 1 to 4 
years to about 30 per cent (serum dilution of 1:4) and it remains close to this 
level through all subsequent ages; thus, unlike the population in Cairo, the 
period of exposure and infection with Type 2  (Lansing) poliomyelitis virus 
does not seem to be confined to early childhood alone, but appears to occur 
frequently in adults as well.  This divergence in findings might  be explained 
by the fact that children in Cairo, being exposed early in life, to repeated and 
heavy doses of virus, build up their antibodies rather quickly, while in Charles- 
ton the process of antibody production  to poliomyelitis virus is a  slow one 
lasting for many years. This last assumption has of  course yet to be proven. 
Evidence  for widespread prevalence  of  poliomyelitis virus  in  Cairo  has  re- 
cently been obtained by Ward who found that poliomyelitis virus could be 
readily detected in flies trapped in this area during a  normal endemic period 
(16). 
SUMMARY 
Sera  collected in 1950  from  the native population  in the vicinity of 
Cairo, Egypt, have been tested for complement-fixing antibodies  to Type  2 
(Lansing)  poliomyelitis  virus. NATAN  GOLDBLUM AND  JOSEPH  L.  MELNICK  185 
Complement-fixing antibodies are confined to the age of 1 to 9 years if a 
serum dilution of 1 : 4 is used in the test, or to the age of 1  to 4  years with a 
serum dilution of 1 : 15. 
A comparison has been made of the findings obtained in this study with the 
results  for  neutralizing  antibodies  previously  reported.  Complement-fixing 
antibodies were found to be temporary in nature while neutralizing antibodies 
were maintained for long periods of time. On this basis, criteria for "recent," 
"old," or "no infection" in poliomyelitis have been established. 
Sixteen of the children were bled again in 1952, 18 months after the first 
bleeding and both series of sera were compared in complement fixation and 
neutralization tests. All children who were negative in 1950 and who developed 
c-f antibodies by 1952, also developed neutralizing antibodies to a titer of more 
than 1 : 250 during the same period.  Some children who failed to develop c-f 
antibodies, did develop neutralizing antibodies although of lower titer than 
found in children in whom c-f antibodies made their appearance. 
These findings are discussed in the light of theories regarding the mode of 
acquisition of antibodies to poliomyelitis virus. 
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